EPF acknowledgement of Financial Support 2011
EPF wishes to thank the following sponsors for their support in the form of unrestricted grants to EPF'S | |||
operational programme 2011 : | |||
% of total income | |||
AMGEN | € 25,000.00 | 3.2% | |
AztraZeneca (1) | € 50,000.00 | 6.3% | |
Baxter | € 10,000.00 | 1.3% | |
CSL Behring | € 10,000.00 | 1.3% | |
GILEAD (2) | € 15,000.00 | 1.9% | |
GSK (3) | € 41,932.89 | 5.3% | |
Janssen Pharmaceutica | € 10,000.00 | 1.3% | |
Microsoft | € 20,000.00 | 2.5% | |
MSD | € 30,000.00 | 3.8% | |
Novartis | € 50,000.00 | 6.3% | |
Pfizer | € 50,000.00 | 6.3% | |
Philips (4) | € 20,000.00 | 2.5% | |
Phrma | € 40,000.00 | 5.1% | |
Sanofi Aventis | € 25,000.00 | 3.2% | |
Sanofi Pasteur MSD | € 20,000.00 | 2.5% | |
Les Laboratoires Servier | € 10,000.00 | 1.3% | |
Shire | € 5,000.00 | 0.6% | |
(1) 2011 contribution received in 2012 | |||
(2) A contribution of € 45,000 was received from GILEAD in 2011 of which € 30,000 related to 2010 and € 15,000 to 2011 | |||
(3) GSK gave honoraria of €1000 and travel of €932,39 to support the attendance of EPF Executive Director at meetings | |||
GSK’s April and November European Health Advisory Board | |||
(4) 2011 contribution received in 2010 | |||
EPF wishes to thank the following sponsors for their support in the form of unrestricted grants to EPF'S | |||
events in 2011 : | |||
Annual General Meeting | |||
Eli Lilly | € 20,000.00 | 2.5% | |
Hoffmann La Roche | € 20,000.00 | 2.5% | |
Janssen Pharmaceutica | € 20,000.00 | 2.5% | |
Regional Advocacy Seminar | |||
Medtronic Foundation | € 30,000.00 | 3.8% | |
SANOFI AVENTIS | € 15,000.00 | 1.9% | |
Conference on Rights and Needs of Older Patients | |||
AMGEN | € 10,000.00 | 1.3% | |
GSK * | € 30,000.00 | 3.8% | |
Novartis | € 30,000.00 | 3.8% | |
Pfizer | € 30,000.00 | 3.8% | |
* 2011 Contribution paid in 2010 | |||
EPF wishes to thank the European Commission for its support in 2011 | |||
in relation to Epf's role in the following projects : | |||
Respect * | € 16,311.00 | 2.1% | |
Renewing Health * | € 27,163.92 | 3.4% | |
Interquality | € 48,094.00 | 6.1% | |
Chain of Trust | € 41,376.65 | 5.2% | |
E-Health Governance | € 4,500.00 | 0.6% | |
* 2011 contribution to be received in 2012 | |||